about
Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humansAdaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapyHigh levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients.Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy.IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells.Tumor-released microvesicles as vehicles of immunosuppression.Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction.Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.Tumour-released exosomes and their implications in cancer immunity.Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients.Recent advances on the role of tumor exosomes in immunosuppression and disease progression.microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy.Immune surveillance properties of human NK cell-derived exosomes.Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site.Proton dynamics in cancer.More insights into the immunosuppressive potential of tumor exosomes.Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators.Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.Tumor Exosomes and Their Impact on Immunity and Cancer ProgressionTumor-Derived Exosomes as Dendritic Cell ModulatorsIdentification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor VaccineIn ReplyHuman Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune EscapeNatural Killer andNK-LikeT-Cell Activation in Colorectal Carcinoma Patients Treated with Autologous Tumor-Derived Heat Shock Protein 96Expression of constitutive nitric oxide synthase in rat and human gastrointestinal tractExpression of endothelial cell-derived nitric oxide synthase (eNOS) is increased during gastric adaptation to chronic aspirin intake in humans
P50
Q28184229-7C135155-EBF7-4AF9-8F00-0F453C4548F8Q33416940-3845E093-CBD3-4F29-A60B-7BC75A208399Q33432819-A29BF788-29EC-4D39-9BDE-32E212E5C5CFQ34029127-9C570021-F3DF-4CF6-B939-DF7D30DB0D60Q34290178-98AFBB95-067D-422A-8072-66667C51C799Q34616014-BFD696CE-1C9B-4EDC-AB82-65B18446D58DQ35005940-C0A561B3-1379-4194-958D-ABE79034EAD4Q36150417-DCF49ACD-2C63-4452-A774-46278C113796Q36370300-CADF8AC4-EE66-4B88-8E77-41424D1B83BFQ36969017-7D357C0F-5C2B-4408-8F0B-A7BEC34816D5Q37961577-C1B8C0A5-B000-40B9-8EA7-B92CA7A21985Q37988647-50322CAE-5829-4150-8194-041C66C80455Q38376771-CD6F66C7-D4CE-423F-87CB-7188E34C407BQ39564433-C24F2690-65D7-4061-837E-32147C21E981Q39567116-B571A080-7468-4F3D-AFFE-EAEB89CA5A73Q40230415-DDFF9067-FE8B-4DB1-9587-5DBEDF42B580Q40539847-0682B6AF-51BB-45FC-8D64-1B781C6B3BB7Q40871383-6FF3B7E5-FADF-4017-8FC2-09775B01A17FQ42730234-AE89B843-48C5-4222-A708-1A2708D9BB9EQ43237241-2A1A45D4-C4ED-4959-B739-E695A072DD9EQ46769764-212E91B2-A18C-4636-B71C-A7DA41DC00A2Q54510441-B91FE414-940C-4B26-9B3F-F1B1EDFCB9D1Q60311219-A3B072D0-99CE-4ECE-989D-E84E2E925231Q60311222-D6E7AABF-23FE-4654-A6EF-A833E02AA879Q60311223-6F8528F1-3757-4127-A64E-86C81CEE529BQ60311224-C2D70A63-4FB8-4E3F-9100-E1560E6DB566Q60311229-0B34B81D-66D3-448B-BF12-E86DB412C37CQ60311231-5444DA0E-4B36-4AB9-BB8B-9D57D06550E9Q60311239-1159F519-C2BC-41E6-8ABF-A8EB958FB0A1Q60311243-96291E36-0D82-4187-A862-9DA9614DD4F5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Veronica Huber
@ast
Veronica Huber
@en
Veronica Huber
@es
Veronica Huber
@nl
Veronica Huber
@sl
type
label
Veronica Huber
@ast
Veronica Huber
@en
Veronica Huber
@es
Veronica Huber
@nl
Veronica Huber
@sl
prefLabel
Veronica Huber
@ast
Veronica Huber
@en
Veronica Huber
@es
Veronica Huber
@nl
Veronica Huber
@sl
P1053
D-1618-2017
P106
P1153
7003743919
P21
P31
P3829
P496
0000-0001-6304-3575